Gerhard Laub1, Randall Kroeker2, Derek Lohan3, Paul Finn3
1Siemens Medical Solutions USA, Los Angeles, CA, USA; 2Siemens Medical Solutions, Canada; 3David Geffen School of Medicine, UCLA
In view of NSF, we tested the feasibility of performing very low dose time-resolved 3D MR angiography in 10 patients and compared with standard dose contrast-enhanced MRA.